Overview
Our unique Guangzhou-Israel Biotechnology Fund (GIBF) creates added value for Israeli, European and American companies looking to expand in China.
With years of life sciences expertise and local knowledge, GIBF serves as an invaluable strategic investor and partner in China for conducting multi-center clinical trials, providing the resources and networks for securing successful NMPA submissions, commercializing products and developing manufacturing capacity to satisfy both local and global demand.
Our Strategy
Enabling value creation by investing in Chinese subsidiaries of foreign companies active in the biomedical outside China
GIBF partners with select companies from Israel, Europe and the USA to establish new JVs in the Chinese market, enabling the foreign companies to manage the new enterprises as the majority shareholders.
Our People
Meet Our Management
Where global leaders in life sciences meet local talent to achieve cross-border investments and companies formation.
DR. YEHOSHUA GLEITMAN
Chairman
PROFESSOR SHLOMO NOY
Chief Medical Officer
AVNER LUSHI
CEO
CARL GENG
Managing Director
Latest News
Kamari Pharma Raises $8 Million from the Sino-Israeli GIBF2 Fund
Kamari Pharma announced the completion of an $8 million investment by the Chinese fund...
GIBF (China-Israel) Fund Raised 300 million Dollars on the Second Fund
The fund, co-owned by Dr. Shuki Gleitman, Prof. Shlomo Noy and Avner Lushi, also...
Opening Ceremony of Guangzhou Sino-Israel Bio Incubation Center
The fund, co-owned by Dr. Shuki Gleitman, Prof. Shlomo Noy and Avner Lushi, also...